Literature DB >> 22068679

Pulmonary pleomorphic carcinoma producing granulocyte-macrophage colony-stimulating factor: report of a case.

Toshinori Fukutomi1, Mitsutomo Kohno, Yotaro Izumi, Masazumi Watanabe, Yuichiro Hayashi, Hiroaki Nomori.   

Abstract

We report a case of lung cancer producing granulocyte-macrophage colony-stimulating factor (GM-CSF). The patient, a 55-year-old woman, was found to have leukocytosis (leukocytes 28.8 × 10(3)/mm3) with eosinophilia (eosinophils 24.5%) without any evidence of infection or allergy. The serum concentration of GM-CSF was elevated to 44 pg/ml (normal range <2.0 pg/ml), which might have induced the leukocytosis and eosinophilia. We performed left pneumonectomy and diagnosed a pleomorphic carcinoma with p-T2bN0M0, based on histological examination of the resected tumor. Immunohistochemical examination revealed GM-CSF. The serum level of GM-CSF decreased to within the normal range 8 days after surgery. At the time of writing, 16 months after the surgery, she was alive without disease. To our knowledge, this represents the first case report of a GM-CSF-producing tumor effectively treated by surgical resection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22068679     DOI: 10.1007/s00595-011-0043-2

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  16 in total

1.  Rhabdoid tumour of the lung is a dedifferentiated phenotype of pulmonary adenocarcinoma.

Authors:  J Miyagi; K Tsuhako; T Kinjo; T Iwamasa; H Hashimoto; S Ishikawa
Journal:  Histopathology       Date:  2000-07       Impact factor: 5.087

2.  Aggressive undifferentiated colon carcinoma producing granulocyte-colony stimulating factor: report of a case.

Authors:  Akihisa Matsuda; Koji Sasajima; Takeshi Matsutani; Hiroshi Maruyama; Masayuki Miyamoto; Tadashi Yokoyama; Seiji Suzuki; Hideyuki Suzuki; Takashi Tajiri
Journal:  Surg Today       Date:  2009-11-01       Impact factor: 2.549

Review 3.  The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells.

Authors:  D Metcalf
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

4.  Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells.

Authors:  W E Berdel; S Danhauser-Riedl; G Steinhauser; E F Winton
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

Review 5.  In vitro assessment of the effects of granulocyte-macrophage colony-stimulating factor on primary human tumors and derived lines.

Authors:  R S Foulke; M H Marshall; P P Trotta; D D Von Hoff
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

6.  Nonhematopoietic tumor cells express functional GM-CSF receptors.

Authors:  G C Baldwin; J C Gasson; S E Kaufman; S G Quan; R E Williams; B R Avalos; A F Gazdar; D W Golde; J F DiPersio
Journal:  Blood       Date:  1989-03       Impact factor: 22.113

7.  Production of granulocyte-macrophage colony-stimulating factor in two patients with lung cancer, leukocytosis, and eosinophilia.

Authors:  C L Sawyers; D W Golde; S Quan; S D Nimer
Journal:  Cancer       Date:  1992-03-15       Impact factor: 6.860

8.  Granulocyte-macrophage colony-stimulating factor may inhibit neutrophil migration in vivo.

Authors:  I E Addison; B Johnson; S Devereux; A H Goldstone; D C Linch
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

9.  The effect of GM-CSF and G-CSF on the growth of human osteosarcoma cells in vitro and in vivo.

Authors:  J D Thacker; S Dedhar; D E Hogge
Journal:  Int J Cancer       Date:  1994-01-15       Impact factor: 7.396

10.  A case of lung cancer associated with granulocytosis and production of colony-stimulating activity by the tumour.

Authors:  T Suda; Y Miura; H Mizoguchi; K Kubota; F Takaku
Journal:  Br J Cancer       Date:  1980-06       Impact factor: 7.640

View more
  5 in total

1.  Colony‑stimulating factor CSF2 mediates the phenotypic plasticity of small‑cell lung cancer by regulating the p‑STAT3/MYC pathway.

Authors:  Hui Li; Rui Zhong; Chunying He; Chenchen Tang; Heran Cui; Rixin Li; Yan Liu; Shaowei Lan; Ying Cheng
Journal:  Oncol Rep       Date:  2022-05-18       Impact factor: 4.136

2.  Hypereosinophilia in Solid Tumors-Case Report and Clinical Review.

Authors:  Ewa Zalewska; Łukasz Obołończyk; Krzysztof Sworczak
Journal:  Front Oncol       Date:  2021-03-24       Impact factor: 6.244

3.  Clinicopathological characteristics, survival outcomes and prognostic factors in pleomorphic carcinoma: a SEER population-based study.

Authors:  Zhongzhong Chen; Jiachang Liu; Lingfeng Min
Journal:  BMC Pulm Med       Date:  2022-03-31       Impact factor: 3.317

Review 4.  G-CSF/GM-CSF-induced hematopoietic dysregulation in the progression of solid tumors.

Authors:  Kai He; Xi Liu; Robert D Hoffman; Rong-Zhen Shi; Gui-Yuan Lv; Jian-Li Gao
Journal:  FEBS Open Bio       Date:  2022-06-09       Impact factor: 2.792

Review 5.  A role for G-CSF and GM-CSF in nonmyeloid cancers.

Authors:  Alexander M Aliper; Victoria P Frieden-Korovkina; Anton Buzdin; Sergey A Roumiantsev; Alex Zhavoronkov
Journal:  Cancer Med       Date:  2014-04-02       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.